ZURICH, Switzerland and BOSTON, US — BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™ (NYSE: IQV). The round was led by IQVIA in conjunction with Debiopharm Innovation Fund and Tesi, a Finnish venture capital and private equity company. As part […]
Capital will enable continued advancement of novel Proteograph™ platform and commercialization of first-in-class proteomics products Seer, Inc., a life sciences company focused on capturing and translating proteome insights to advance human health, today announced it has raised $55 million in an oversubscribed Series D equity financing. The round was led by healthtech and life sciences […]
SEATTLE — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue biopsy analysis platforms with emphasis on rare cell detection announced today the completion of a $22M financing from new and existing investors. The funding will drive a global sales expansion for its instrument and consumables platform used in research […]
New Funding Brings Total Amount Raised by the Company to $259.5 Million Inscripta, Inc., today announced the company has raised $125 million in a Series D financing with support from the company’s existing investors and new investors JS Capital Management LLC and Oak HC/FT. Paladin Capital Group led the round, bringing the total amount raised […]
Additional Resources Will Support Continued Commercialization of Akoya’s Spatial Biology Platforms CODEX® and Phenoptics™ Company to present at Piper Jaffray 31st Annual Healthcare Conference Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the completion of a $50 million financing from both new and existing investors. The round will fund significant growth through expansion of commercial […]
BioData announces 60 percent Year to Date Annual Recurring Revenue (ARR) growth following record third quarter results Cambridge, MA: CEO at BioData, Steve Yemm, announces a record-breaking third quarter for the software business following a YTD 60 percent annual recurring revenue (ARR) growth throughout 2019. The company’s Labguru electronic lab notebook (ELN) is giving labs […]
DNAnexus’ FedRAMP-authorized cloud-based platform exemplifies FDA strategy for enhancing the regulatory process through data, technology, and stakeholder engagement. MOUNTAIN VIEW, Calif. – DNAnexus, Inc., the leader in Enterprise Omics Technology, today announced that the U.S. Food and Drug Administration (FDA) has awarded DNAnexus a five-year, $20 million contract to power the precisionFDA Collaborative Omics Environment in the […]
The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand access to genetic health insights Redwood City, CA — GenapSys Inc. announced today that it has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate […]
WHITEFISH, Mont. — xD Bio Inc., a privately held, Montana-based company announced today that the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has awarded the company $149,959 over 6 months for the first phase of a Small Business Technology Transfer (STTR) grant. The award supports researchers at xD Bio and collaborators at […]
RESEARCH TRIANGLE PARK, N.C. — RTI International, a leading research institute, today announced a follow-on investment in PierianDx to help empower leading health institutions and diagnostic laboratories to build world-class precision medicine programs. The transaction includes RTI’s participation in a $27 million Series B funding round, which includes new investors ATW Partners and SJF Ventures along with […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
